United States · FDA National Drug Code directory
AMMONIA N-13
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 52768-100_318c2020-f260-4b67-8df3-95ee2cf2b49e
- Product NDC
- 52768-100
- Form
- INJECTION, SOLUTION
- Composition / generic term
- AMMONIA N-13
- Labeler
- Precision Nuclear LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101010
- Source listing expiry
- 20261231
Source-listed ingredients
- AMMONIA N-13 — 260 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 3 mL in 1 SYRINGE (52768-100-03) · 52768-100-03
- 5 mL in 1 SYRINGE (52768-100-05) · 52768-100-05
- 30 mL in 1 VIAL, MULTI-DOSE (52768-100-30) · 52768-100-30
- 50 mL in 1 VIAL, MULTI-DOSE (52768-100-50) · 52768-100-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →